SUPPORT OUR JOURNALISM: Please consider donating to keep our website running and free for all - thank you!


Queen Letizia speaks passionately on need for support for rare diseases

The fight against rare diseases is something that has always been important for Queen Letizia of Spain who has attended a meeting, digitally, at the United Nation to once again shed light on this very important topic.

The Queen of Spain gave a digital greeting in which she said: “I will tell you that a WHO resolution would bring the necessary commitment from member countries to share the actions that are already underway and generate a more solid joint path towards equity. I hope it’s possible.”

Spain, Qatar and Brazil completed in 2021 the UN Resolution on Rare Diseases, to address the causes of discrimination through disclosure and to collect, compile and disseminate data on rare diseases.

Queen Letizia is the Honorary President of FEDER which was established in 1999. FEDER is a Spanish organisation with the aim of raising awareness about these diseases, which affect a large number of people in Spain and around the world.

On the same day as the digital address to the United Nations, Queen Letizia visited London. During her stay in the UK, Her Majesty visited the Cancer Research UK head office in London. Queen Letizia is also the honorary president of the Spanish Association Against Cancer and her visit was to put a focus on World Cancer Research Day which is on September 24.

"; n.innerHTML = "window._taboola = window._taboola || [];_taboola.push({mode:'thumbnails-a', container:'taboola-below-article-thumbnails', placement:'Below Article Thumbnails', target_type: 'mix'});"; insertAfter(t, e); insertAfter(n, t) }injectWidgetByMarker('tbmarker');

About author

Senior Europe Correspondent Oskar Aanmoen has a master in military and political history of the Nordic countries. He has written six books on historical subjects and more than 1.500 articles for Royal Central. He has also interview both Serbian and Norwegian royals. Aanmoen is based in Oslo, Norway.